[PDF][PDF] In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer

F Pagès, A Kirilovsky, B Mlecnik, M Asslaber… - Journal of clinical …, 2009 - academia.edu
F Pagès, A Kirilovsky, B Mlecnik, M Asslaber, M Tosolini, G Bindea, C Lagorce, P Wind
Journal of clinical oncology, 2009academia.edu
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal
Cancer Page 1 In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With
Early-Stage Colorectal Cancer Franck Page`s, Amos Kirilovsky, Bernhard Mlecnik, Martin
Asslaber, Marie Tosolini, Gabriela Bindea, Christine Lagorce, Philippe Wind, Florence Marliot,
Patrick Bruneval, Kurt Zatloukal, Zlatko Trajanoski, Anne Berger, Wolf-Herman Fridman, and
Jérôme Galon From the AVENIR L’Institut National de la Santé et de la Recherche Médicale …
Purpose
Many patients who present with early-stage colorectal cancer (International Union Against Cancer TNM stages I and II) are nevertheless at high risk of relapse. We hypothesized that intratumoral immune reaction could influence their prognosis.
academia.edu